[The significance of the myotonolytics in rheumatic diseases].
D012216:Rheumatic Diseases / Q000628:therapy*; D015049:Zoxazolamine / Q000031:analogs & derivatives*
D015049:Zoxazolamine
RHEUMATISM/therapy; ZOXAZOLAMINE/related compounds